NCT00725062 2017-11-29Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 1 Terminated3 enrolled